Old Web
English
Sign In
Acemap
>
authorDetail
>
Giles Best
Giles Best
University of Sydney
Immunology
Medicine
Chronic lymphocytic leukemia
Fludarabine
Rituximab
7
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Quality of Life in Fit Elderly Patients with Chronic Lymphocytic Leukemia (CLL) Receiving Oral Fludarabine-Based Regimens As First Line Therapy: Australasian Leukaemia and Lymphoma Group (ALLG) CLL5 Trial
2015
Blood
Suneet Sandhu
Devinder Gill
Paul Turner
William Renwick
Maya Latimer
Naomi Mackinlay
Leanne Berkahn
David R Simpson
Philip Campbell
Cecily Forsyth
Gavin Cull
Rosemary Harrup
Giles Best
Mathias Bressel
Juliana Di Iulio
Bryone J. Kuss
Stephen P. Mulligan
Show All
Source
Cite
Save
Citations (0)
Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
2014
Blood
Stephen P. Mulligan
Devinder Gill
Paul Turner
William Renwick
Maya Latimer
Naomi Mackinlay
Leanne Berkahn
David R Simpson
Philip Campbell
Cecily Forsyth
Gavin Cull
Rosemary Harrup
Melanie Sulda
Giles Best
Mathias Bressel
Juliana Di Iulio
Bryone J. Kuss
Show All
Source
Cite
Save
Citations (6)
A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity
2014
Blood
Stephen P. Mulligan
Devinder Gill
Paul Turner
William Renwick
Maya Latimer
Naomi Mackinlay
Leanne Berkahn
David Simpson
Philip Campbell
Cecily Forsyth
Gavin Cull
Rosemary Harrup
Melanie Sulda
Giles Best
Mathias Bressel
Juliana Di Iulio
Bryone J. Kuss
Show All
Source
Cite
Save
Citations (16)
1